Form 8-K - Current report:
SEC Accession No. 0001104659-23-011167
Filing Date
2023-02-06
Accepted
2023-02-06 16:06:20
Documents
13
Period of Report
2023-02-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm235492d1_8k.htm   iXBRL 8-K 26521
2 EXHIBIT 3.1 tm235492d1_ex3-1.htm EX-3.1 262030
  Complete submission text file 0001104659-23-011167.txt   512143

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gild-20230206.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20230206_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20230206_pre.xml EX-101.PRE 22591
7 EXTRACTED XBRL INSTANCE DOCUMENT tm235492d1_8k_htm.xml XML 3601
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 23590712
SIC: 2836 Biological Products, (No Diagnostic Substances)